• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA awarded record number of review designations to CRISPR drugs in 2023

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 06, 2024 at 09:22: AM
via In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gaining the first FDA approval for a CRISPR-based drug, exagamglogene autotemcel (Casgevy) for the treatment of sickle cell disease with vaso-occlusive crisis.

article source
 

<



Similar threads

cafead
Vanda Contests FDA Rejection of Gastroparesis Drug, Slams ‘Delayed’ Decision
Replies
0
Views
2
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Elanco&#039;s skin disease treatment for dogs
Replies
0
Views
10
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
Replies
1
Views
25
Pharma/Biotech Companies - In the News
anonymous
cafead
FDA inspection backlog overseas threatens new drug approvals
Replies
0
Views
3
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote